The body's immune reaction to increased levels of a toxic molecule, part of a bacterial species in the human gut, may reveal ...
A cross-disciplinary team led by Prof. Qu Jianan from the Department of Electronic and Computer Engineering and Prof. Julie L ...
A new Yale study published in JAMA Network Open finds that the virus that causes COVID-19 does not linger in placental tissue ...
For many years, a dominant view in neuroscience was that neurons in the inferotemporal (IT) cortex—a critical center in the ...
9h
Virtual vs. in-person visits for new neurology patients show no impact on future care, finds study
For people who see a neurology clinician for the first time, a new study has found that being seen virtually vs. in person ...
An experimental drug targeting triple-negative breast cancer overwhelms cancer cells with toxic fats, according to new tests ...
Researchers from Drexel University's College of Medicine have identified a critical metabolic vulnerability in breast cancer ...
9h
Targeted therapy to manage kidney complications may enable continuation of lifesaving immunotherapy
Immune checkpoint inhibitors (ICIs) have transformed treatment for many types of cancer. In some patients, however, ICIs are ...
How fit you are in midlife may help determine not just how long you live, but how many of those years are spent in good ...
Adopted children who have grown up in more favorable family environments than their siblings are at lower risk of mental ...
Parents say they just want their teenage children to be happy, but often they struggle to simply get along in the same house, ...
SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment. It causes epilepsy, intellectual disability, psychomotor delay and, frequently, autism. It arises from mutations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results